Neurocompute scores pediatric oncology literature, surfaces overlooked therapeutic signals, and turns fragmented childhood cancer research into a living discovery terminal.
A grade PMID 42321916
View analysis →A grade PMID 42690647
View analysis →A grade PMID 42372741
View analysis →A grade PMID 42216567
View analysis →A grade PMID 41916649
View analysis →A grade PMID 42382416
View analysis →A grade PMID 42150584
View analysis →A grade PMID 41756844
View analysis →A grade PMID 42362103
View analysis →A grade PMID 42101908
View analysis →A grade PMID 42248607
View analysis →A grade PMID 41667193
View analysis →In this prospective single-centre cohort of paediatric haemato-oncology febrile-neutropenia admissions, respiratory support and lower admission albumin were strongly associated with in-hospital mortality, while age, albumin, respiratory support, and gram-negative bacteraemia were associated with prolonged fever or death before defervescence.
The evidence supports these routinely available variables as candidate prognostic markers; it is only an inference that externally validated risk models using them could enable earlier escalation, targeted monitoring, or treatment selection and thereby improve outcomes.
This single-institution retrospective cohort reports perioperative outcomes for robot-assisted thoracoscopic resection of mediastinal tumors in 168 children and identifies tumor size greater than 5 cm and malignant pathology as risk factors for adverse perioperative outcomes.
The evidence supports the feasibility of robot-assisted thoracoscopic resection in selected pediatric patients at an experienced institution; it is reasonable but unproven to hypothesize that tumor size and pathology could guide surgical selection and perioperative planning, because no comparator group or prospective validation is reported.
In FCM images from 141 specimens obtained from 42 children, a convolutional neural network classified malignant, benign, and healthy tissue, detecting malignant tiles with 91.35% accuracy and producing heatmaps that highlighted cellular-level architectural distortion.
The evidence supports feasibility for automated, spatially interpretable classification of pediatric tissue on ex vivo FCM images; it remains an inference that prospective intraoperative use could improve real-time surgical decision-making or clinical outcomes.
In a Romanian national registry cohort of 6247 pediatric and adolescent cancer patients, greater regional and county deprivation and rural residence were associated with poorer survival, including a 44% higher adjusted risk of death for rural versus urban patients.
The evidence identifies geographic and socioeconomic survival disparities but does not test a therapy; it supports the inference that interventions improving timely proximity-based access to quality oncology care for rural and deprived populations could reduce outcome gaps, a hypothesis requiring prospective evaluation.
This pediatric-focused review describes the clinical diagnosis and neuroblastoma evaluation of opsoclonus-myoclonus-ataxia syndrome and reports that early multimodal immunotherapy is associated with fewer relapses and better neurological outcomes.
The supplied review states that early combinations of corticosteroids, immunoglobulin, and immunosuppressive agents are associated with improved outcomes; it can therefore be hypothesized—but not established from this record—that earlier, intensive immune modulation may limit relapse and neurological sequelae in children with this neuroblastoma-associated syndrome.
This manuscript reports a consensus-based Pan-Asian adaptation of the 2025 ESMO guidelines for HCC diagnosis, treatment, and follow-up, incorporating Western and Asian trial evidence and discussing regional differences in drug approval, access, and reimbursement.
The record supports the use of regionally adapted consensus guidance to harmonize HCC management across Asian countries; it is reasonable to infer that implementation could improve treatment selection and consistency, but the abstract provides no evidence of improved outcomes and no pediatric-specific recommendation or validation.
In a 204-patient observational comparison of meningiomas treated with stereotactic radiosurgery, prior childhood tinea capitis irradiation was associated with multifocal disease and poorer volumetric response, but not with progression-free survival or greater need for surgery.
The evidence supports prior childhood scalp irradiation as a potential predictor of reduced meningioma shrinkage after stereotactic radiosurgery; it is an inference—not demonstrated here—that this history could guide individualized surveillance, radiosurgery planning, or selection of alternative management strategies.
This review synthesizes classical and emerging multidimensional epigenomic research in medulloblastoma, linking tumor heterogeneity and cellular plasticity with molecular classification, biomarkers, disease monitoring, and prospective precision therapies.
The supplied record supports epigenetic alterations as biomarkers and contributors to aberrant transcriptional programs and therapeutic resistance; it is reasonable, but still inferential, to hypothesize that subgroup- and state-specific epigenetic vulnerabilities could guide targeted therapy or monitoring, because no therapeutic intervention or clinical outcome is reported here.
In patient-derived DIPG cell lines, resveratrol pretreatment enhanced hrR3 oncolytic herpesvirus replication and reduced tumor-cell viability more than either monotherapy, alongside reduced STAT3/AKT phosphorylation and increased apoptotic markers.
The record provides in-vitro evidence that resveratrol potentiates hrR3-mediated oncolysis in DIPG cells; it remains an inference that this combination could improve antitumor efficacy in patients, pending validation in animal models and human studies of delivery, dosing, safety, and efficacy.
This scoping review of 18 studies comprising 365 patients reports heterogeneous definitions of idiopathic syringomyelia, generally favorable conservative outcomes in clinically stable children, and evidence that occult arachnoid or cerebrospinal-fluid-flow abnormalities may underlie many adult cases.
The reviewed evidence supports clinical observation for many stable pediatric cases and substrate-directed surgery in selected symptomatic patients with identified arachnoid pathology; any relevance to pediatric oncology is indirect because tumor-associated syringomyelia was explicitly excluded, so application to children with cancer would require separate study.
In 14 young Jordanian patients with clinical or immunohistochemical evidence of mismatch repair deficiency, the study identified pathogenic or likely pathogenic mismatch-repair variants in nine families, characterized tumor mutational features, and found one ultrahypermutated tumor with a somatic POLE proofreading-domain mutation.
The reported germline and tumor molecular findings support improved identification of CMMRD/Lynch-associated cancers and molecular stratification in this population; it is plausible—but not tested here—that validated MMRD, hypermutation, or combined MMRD–POLE status could inform treatment selection or surveillance.
In 143 surgically treated patients with skull-base juvenile nasopharyngeal angiofibroma, the internally validated GVV score predicted several intraoperative bleeding outcomes better than the Fisch-Andrews and UPMC systems and showed comparable recurrence discrimination.
The evidence supports the GVV score as a prognostic risk-stratification tool within the analyzed cohort; it may, by inference, help tailor perioperative preparation, bleeding-mitigation strategies, and recurrence surveillance, but the record does not show that score-guided management improves clinical outcomes.
